Value proposition

Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs.

Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.

We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025.

Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to help dogs everywhere.